First Niagara Bank’s Gilead Sciences GILD Stock Holding History

First Niagara Bank’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$1.89M	Buy	22,640 +1,135	+5%	+$101K	0.54%	52
2016 Q1	$1.98M	Buy	21,505 +2,016	+10%	+$182K	0.58%	45
2015 Q4	$1.97M	Sell	19,489 -1,101	-5%	-$115K	0.55%	53
2015 Q3	$2.02M	Buy	20,590 +3,914	+23%	+$435K	0.53%	54
2015 Q2	$1.95M	Buy	16,676 +1,586	+11%	+$173K	0.44%	65
2015 Q1	$1.48M	Buy	+15,090	New	+$1.53M	0.33%	82

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Niagara Bank's GILD Position: Q2 2016 in Review

First Niagara Bank increased its Gilead Sciences (GILD) stake by 5.3% in Q2 2016, buying an estimated $101K and bringing the position to 22,640 shares worth $1.89M. The position accounts for 0.54% of the portfolio, ranked #52.

First Niagara Bank first reported a position in GILD in Q1 2015 and has held it in 6 quarters since. The position peaked at $2.02M in Q3 2015. 1,597 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

First Niagara Bank held 22,640 shares of Gilead Sciences worth $1.89M as of Q2 2016.
First Niagara Bank bought 1,135 Gilead Sciences shares in Q2 2016, an estimated $101K.
Gilead Sciences made up 0.54% of First Niagara Bank's portfolio in Q2 2016, its #52 holding.
First Niagara Bank first reported a position in Gilead Sciences in Q1 2015 and has held it in 6 quarters since.
First Niagara Bank's Gilead Sciences position peaked at $2.02M in Q3 2015.
1,597 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on First Niagara Bank's 13F filing for Q2 2016, filed 25 Jul 2016.